- Broschiertes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Part of the Drugs in series, this easily accessible pocket-sized guide covers the optimal use of medications when treating patients with neurological ailments.
Andere Kunden interessierten sich auch für
Andrea E CavannaBehavioural Neurology of Anti-Epileptic Drugs56,99 €
Drugs in Neurology86,99 €
Basant K PuriDrugs in Psychiatry81,99 €
Magdy H SelimNeurology Emergencies74,99 €
Essentials of Hospital Neurology109,99 €
Dementia89,99 €
Eelco F M Wijdicks MD FacpThe Practice of Emergency and Critical Care Neurology28,99 €-
-
-
Part of the Drugs in series, this easily accessible pocket-sized guide covers the optimal use of medications when treating patients with neurological ailments.
Produktdetails
- Produktdetails
- Verlag: Oxford University Press
- 2nd edition
- Seitenzahl: 792
- Erscheinungstermin: 26. Juni 2025
- Englisch
- Abmessung: 173mm x 99mm x 25mm
- Gewicht: 522g
- ISBN-13: 9780198869696
- ISBN-10: 019886969X
- Artikelnr.: 73802659
- Herstellerkennzeichnung
- Libri GmbH
- Europaallee 1
- 36244 Bad Hersfeld
- gpsr@libri.de
- Verlag: Oxford University Press
- 2nd edition
- Seitenzahl: 792
- Erscheinungstermin: 26. Juni 2025
- Englisch
- Abmessung: 173mm x 99mm x 25mm
- Gewicht: 522g
- ISBN-13: 9780198869696
- ISBN-10: 019886969X
- Artikelnr.: 73802659
- Herstellerkennzeichnung
- Libri GmbH
- Europaallee 1
- 36244 Bad Hersfeld
- gpsr@libri.de
Sathiji K Nageshwaran completed his medical training at University College London and doctoral work at Imperial College London, synthetic biology training in the lab of George Church at Harvard Medical School and residency in Neurology at Mount Sinai Hospital. He is currently a Neurogenetics Fellow at UCLA in the lab of Daniel Geschwind. David Ledingham completed his medical training at the University of Cambridge and University College London. He is currently a Consultant Neurologist at Newcastle Hospitals and is an Honorary Senior Lecturer at Newcastle University. His clinical interests include movement disorders, deep brain stimulation and botulinum toxin injections. He is actively involved in research and clinical trials in the fields of Parkinson's disease, atypical Parkinson's and dystonia. Dr Heather Wilson is a senior consultant neurologist who joined the MS team at the National Hospital for Neurology and Neurosurgery at UCL in 2020, after working as a general neurologist and MS specialist at the Royal Free NHS Foundation Trust for 16 years. She has experience in managing all aspects of Multiple Sclerosis including all of the licensed disease-modifying therapies, and is committed to MS service development and optimisation. She graduated from Guy's Hospital Medical School in 1990 and undertook her Neurology specialist training in London (King's College Hospital, NHNN and the Royal Free Hospital). She has a PhD in Neuro-immunology from Cambridge University and has an ongoing interest in the immunopathology of MS. She is nationally recognised in the field of MS and reglarly speaks on the topic at national and local levels.
Section 1 - Neurological conditions
1: Headache
2: Vertigo
3: Epilepsy
4: Cerebrovascular disease
5: Neuropathic pain
6: Multiple sclerosis and related disorders
7: Other inflammatory disorders of the central nervous system
8: Disorders of peripheral nerves
9: Motor neuron disease
10: Disorders of muscle
11: Disorders of the neuromuscular junction
12: Parkinson's disease and parkinsonism
13: Hyperkinetic movement disorders
14: Dementia
15: Spasticity
16: Neuro- oncology
17: Sleep disorders
18: Neurological infections
19: Metabolic disorders
20: Uro- neurology
21: Drugs causing neurological disease
22: Neurogenetics
Section 2 - Drugs
23: Drug Classes
24: A- Z Index of neurological drugs
1: Headache
2: Vertigo
3: Epilepsy
4: Cerebrovascular disease
5: Neuropathic pain
6: Multiple sclerosis and related disorders
7: Other inflammatory disorders of the central nervous system
8: Disorders of peripheral nerves
9: Motor neuron disease
10: Disorders of muscle
11: Disorders of the neuromuscular junction
12: Parkinson's disease and parkinsonism
13: Hyperkinetic movement disorders
14: Dementia
15: Spasticity
16: Neuro- oncology
17: Sleep disorders
18: Neurological infections
19: Metabolic disorders
20: Uro- neurology
21: Drugs causing neurological disease
22: Neurogenetics
Section 2 - Drugs
23: Drug Classes
24: A- Z Index of neurological drugs
Section 1 - Neurological conditions
1: Headache
2: Vertigo
3: Epilepsy
4: Cerebrovascular disease
5: Neuropathic pain
6: Multiple sclerosis and related disorders
7: Other inflammatory disorders of the central nervous system
8: Disorders of peripheral nerves
9: Motor neuron disease
10: Disorders of muscle
11: Disorders of the neuromuscular junction
12: Parkinson's disease and parkinsonism
13: Hyperkinetic movement disorders
14: Dementia
15: Spasticity
16: Neuro- oncology
17: Sleep disorders
18: Neurological infections
19: Metabolic disorders
20: Uro- neurology
21: Drugs causing neurological disease
22: Neurogenetics
Section 2 - Drugs
23: Drug Classes
24: A- Z Index of neurological drugs
1: Headache
2: Vertigo
3: Epilepsy
4: Cerebrovascular disease
5: Neuropathic pain
6: Multiple sclerosis and related disorders
7: Other inflammatory disorders of the central nervous system
8: Disorders of peripheral nerves
9: Motor neuron disease
10: Disorders of muscle
11: Disorders of the neuromuscular junction
12: Parkinson's disease and parkinsonism
13: Hyperkinetic movement disorders
14: Dementia
15: Spasticity
16: Neuro- oncology
17: Sleep disorders
18: Neurological infections
19: Metabolic disorders
20: Uro- neurology
21: Drugs causing neurological disease
22: Neurogenetics
Section 2 - Drugs
23: Drug Classes
24: A- Z Index of neurological drugs







